Search

Search bills, members, committees and pages...

Sign In

DEVON FOLTZ

PreviousNext

16 federal lobbying filings, 2023 to 2026.

DEVON FOLTZ is a registered lobbyist named on 16 federal lobbying filings, 2023 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

1 they have filed under, by filings.

RegistrantFilingsReported
ABBOTT LABORATORIES16—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262—$2.6M
20254—$4.6M
20245—$5.5M
20235—$4.9M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues16
MMMMedicare/Medicaid16
TRDTrade (domestic/foreign)16
AGRAgriculture15
TAXTaxation/Internal Revenue Code15
FOOFood Industry (safety, labeling, etc.)7
LAWLaw Enforcement/Crime/Criminal Justice5
VETVeterans5
CSPConsumer Issues/Safety/Products4
BUDBudget/Appropriations3
TARTariff (miscellaneous tariff bills)3
TRATransportation3
FINFinancial Institutions/Investments/Securities1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 2300To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and fo…6
S. 3387One Fair Price Act of 20254
H.R. 1770Consumer Safety Technology Act3
H.R. 1835MERIT Act3
H.R. 9817Justice for Incarcerated Moms Act3
S. 1000A bill to establish an Ambassador-at-Large for Arctic Affairs.3
S. 2477End Solitary Confinement Act3
H.R. 4958GRAS Act2
S. 2426Equitable Community Access to Pharmacist Services Act2
H.R. 3164Ensuring Community Access to Pharmacist Services Act1
H.R. 5269RESULTS Act1
H.R. 7118Genomic Answers for Children’s Health Act of 20261
H.R. 7164Capping Costs for Consumers Act of 20261
H.R. 7966Hospice CARE Act of 20261
S. 2003Strengthening Benefit Plans Act of 20251
S. 2761RESULTS Act1
S. 2922HOV Lane Exemption Reauthorization Act1
S. 4118Hospice CARE Act of 20261

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
ABBOTT LABORATORIESABBOTT LABORATORIES2026 second_quarter$1.2MJul 20, 2026
ABBOTT LABORATORIESABBOTT LABORATORIES2026 first_quarter$1.4MApr 20, 2026
ABBOTT LABORATORIESABBOTT LABORATORIES2025 fourth_quarter$900KJan 21, 2026
ABBOTT LABORATORIESABBOTT LABORATORIES2025 third_quarter$1.1MOct 20, 2025
ABBOTT LABORATORIESABBOTT LABORATORIES2025 second_quarter$813.5KJul 21, 2025
ABBOTT LABORATORIESABBOTT LABORATORIES2025 first_quarter$1.8MApr 21, 2025
ABBOTT LABORATORIESABBOTT LABORATORIES2024 fourth_quarter$1.1MJan 21, 2025
ABBOTT LABORATORIESABBOTT LABORATORIES2024 fourth_quarter$1.1MJan 20, 2025
ABBOTT LABORATORIESABBOTT LABORATORIES2024 third_quarter$1.1MOct 22, 2024
ABBOTT LABORATORIESABBOTT LABORATORIES2024 second_quarter$910KJul 22, 2024
ABBOTT LABORATORIESABBOTT LABORATORIES2024 first_quarter$1.4MApr 22, 2024
ABBOTT LABORATORIESABBOTT LABORATORIES2023 fourth_quarter$810KJan 22, 2024
ABBOTT LABORATORIESABBOTT LABORATORIES2023 third_quarter$1.2MOct 20, 2023
ABBOTT LABORATORIESABBOTT LABORATORIES2023 first_quarter$1.1MSep 29, 2023
ABBOTT LABORATORIESABBOTT LABORATORIES2023 second_quarter$850KJul 20, 2023
ABBOTT LABORATORIESABBOTT LABORATORIES2023 first_quarter$1MApr 20, 2023